IPSC
Price
$0.51
Change
-$0.02 (-3.77%)
Updated
Aug 8 closing price
Capitalization
43.71M
89 days until earnings call
VTGN
Price
$2.97
Change
+$0.24 (+8.79%)
Updated
Aug 8 closing price
Capitalization
88.68M
Interact to see
Advertisement

IPSC vs VTGN

Header iconIPSC vs VTGN Comparison
Open Charts IPSC vs VTGNBanner chart's image
Century Therapeutics
Price$0.51
Change-$0.02 (-3.77%)
Volume$655.48K
Capitalization43.71M
VistaGen Therapeutics
Price$2.97
Change+$0.24 (+8.79%)
Volume$449.08K
Capitalization88.68M
IPSC vs VTGN Comparison Chart in %
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. VTGN commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (IPSC: $0.51 vs. VTGN: $2.97)
Brand notoriety: IPSC and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 63% vs. VTGN: 150%
Market capitalization -- IPSC: $43.71M vs. VTGN: $88.68M
IPSC [@Biotechnology] is valued at $43.71M. VTGN’s [@Biotechnology] market capitalization is $88.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • IPSC’s TA Score: 3 bullish, 7 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а -4.62% price change this week, while VTGN (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($88.7M) has a higher market cap than IPSC($43.7M). VTGN YTD gains are higher at: 0.678 vs. IPSC (-49.772). IPSC has higher annual earnings (EBITDA): -5.99M vs. VTGN (-52.22M). IPSC has more cash in the bank: 165M vs. VTGN (88.6M). VTGN has less debt than IPSC: VTGN (1.71M) vs IPSC (52.7M). IPSC has higher revenues than VTGN: IPSC (115M) vs VTGN (698K).
IPSCVTGNIPSC / VTGN
Capitalization43.7M88.7M49%
EBITDA-5.99M-52.22M11%
Gain YTD-49.7720.678-7,341%
P/E RatioN/AN/A-
Revenue115M698K16,476%
Total Cash165M88.6M186%
Total Debt52.7M1.71M3,076%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCVTGN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 17 days ago
82%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKRIY14.850.26
+1.79%
Bank Ireland Group PLC
AMFC23.30N/A
N/A
AMB Financial Corp.
POELF4.00N/A
N/A
Portucel-Empresa Produtora de Pasta e Papel S.A.
KCLI36.00-0.12
-0.33%
Kansas City Life Insurance Co.

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-4.14%
CRSP - IPSC
57%
Loosely correlated
-2.38%
ARWR - IPSC
54%
Loosely correlated
+2.24%
NTLA - IPSC
51%
Loosely correlated
-5.85%
RXRX - IPSC
50%
Loosely correlated
-0.92%
IMNM - IPSC
50%
Loosely correlated
-1.82%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with RNA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+8.79%
RNA - VTGN
42%
Loosely correlated
-2.59%
COGT - VTGN
42%
Loosely correlated
+0.92%
CRSP - VTGN
41%
Loosely correlated
-2.38%
IPSC - VTGN
41%
Loosely correlated
-4.14%
OCUL - VTGN
41%
Loosely correlated
-0.73%
More